Timothy R. Vollmer

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

Pharmacy, Neurology, Pharmacotherapy +15

THE FUNCTIONS OF SELF‐INJURIOUS BEHAVIOR: AN EXPERIMENTAL‐EPIDEMIOLOGICAL ANALYSIS

Brian A. Iwata, Gary M. Pace, Michael F. Dorsey et al. · Journal of Applied Behavior Analysis · 1994 · 840 citations

Public Health, Behavioral Sciences, Psychology +11

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 512 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Timothy R. Vollmer, Lyndon Key, Valerie Durkalski et al. · The Lancet · 2004 · 470 citations

Life Sciences, Neurology, Pharmacotherapy +7